{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:00:26Z","timestamp":1781625626356,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,4,6]],"date-time":"2012-04-06T00:00:00Z","timestamp":1333670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12185-012-1056-3","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T11:25:51Z","timestamp":1333625151000},"page":"725-730","source":"Crossref","is-referenced-by-count":22,"title":["Successful treatment by donor lymphocyte infusion of adult T-cell leukemia\/lymphoma relapse following allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"95","author":[{"given":"Tomohiko","family":"Kamimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikiyo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nagafuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,6]]},"reference":[{"key":"1056_CR1","unstructured":"Swerdlow SH, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. 1st ed. Lyon: IARC; 2008."},{"key":"1056_CR2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481\u201392.","journal-title":"Blood"},{"key":"1056_CR3","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","volume":"81","author":"M Yoshida","year":"1984","unstructured":"Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA. 1984;81:2534\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1056_CR4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1200\/JCO.1988.6.7.1088","volume":"6","author":"M Shimoyama","year":"1988","unstructured":"Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K, et al. Major prognostic factors of adult patients with advanced T-cell lymphoma\/leukemia. J Clin Oncol. 1988;6:1088\u201397.","journal-title":"J Clin Oncol"},{"key":"1056_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0609.2007.01016.x","volume":"80","author":"K Ishitsuka","year":"2008","unstructured":"Ishitsuka K, Tamura K. Treatment of adult T-cell leukemia\/lymphoma: past, present, and future. Eur J Haematol. 2008;80:185\u201396.","journal-title":"Eur J Haematol"},{"key":"1056_CR6","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25:5458\u201364.","journal-title":"J Clin Oncol"},{"key":"1056_CR7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2141.2003.04054.x","volume":"120","author":"M Kami","year":"2003","unstructured":"Kami M, Hamaki T, Miyakoshi S, Murashige N, Kanda Y, Tanosaki R, et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia\/lymphoma. Br J Haematol. 2003;120:304\u20139.","journal-title":"Br J Haematol"},{"key":"1056_CR8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.leu.2403682","volume":"19","author":"T Fukushima","year":"2005","unstructured":"Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, Masuda M, et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma. Leukemia. 2005;19:829\u201334.","journal-title":"Leukemia"},{"key":"1056_CR9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/bmt.2008.39","volume":"41","author":"K Yonekura","year":"2008","unstructured":"Yonekura K, Utsunomiya A, Takatsuka Y, Takeuchi S, Tashiro Y, Kanzaki T, et al. Graft-versus-adult T-cell leukemia\/lymphoma effect following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;41:1029\u201335.","journal-title":"Bone Marrow Transplant"},{"key":"1056_CR10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/bmt.2011.27","volume":"46","author":"M Jabbour","year":"2011","unstructured":"Jabbour M, Tuncer H, Castillo J, Butera J, Roy T, Pojani J, et al. Hematopoietic SCT for adult T-cell leukemia\/lymphoma: a review. Bone Marrow Transplant. 2011;46:1039\u201344.","journal-title":"Bone Marrow Transplant"},{"key":"1056_CR11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbmt.2006.09.002","volume":"13","author":"K Kato","year":"2007","unstructured":"Kato K, Kanda Y, Eto T, Muta T, Gondo H, Taniguchi S, et al. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia\/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program. Biol Blood Marrow Transplant. 2007;13:90\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1056_CR12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.bbmt.2008.04.014","volume":"14","author":"S Shiratori","year":"2008","unstructured":"Shiratori S, Yasumoto A, Tanaka J, Shigematsu A, Yamamoto S, Nishio M, et al. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia\/lymphoma (ATL): clinical impact of graft-versus-leukemia\/lymphoma effect. Biol Blood Marrow Transplant. 2008;14:817\u201323.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1056_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bmt.2010.92","volume":"46","author":"I Choi","year":"2011","unstructured":"Choi I, Tanosaki R, Uike N, Utsunomiya A, Tomonaga M, Harada M, et al. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: results of prospective trials. Bone Marrow Transplant. 2011;46:116\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1056_CR14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2003-02-0342","volume":"103","author":"HJ Kolb","year":"2004","unstructured":"Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood. 2004;103:767\u201376.","journal-title":"Blood"},{"key":"1056_CR15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2141.2009.07886.x","volume":"147","author":"O Ringden","year":"2009","unstructured":"Ringden O, Karlsson H, Olsson R, Omazic B, Uhlin M. The allogeneic graft-versus-cancer effect. Br J Haematol. 2009;147:614\u201333.","journal-title":"Br J Haematol"},{"key":"1056_CR16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1517\/14712598.2011.554811","volume":"11","author":"C Roddie","year":"2011","unstructured":"Roddie C, Peggs KS. Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation. Expert Opin Biol Ther. 2011;11:473\u201387.","journal-title":"Expert Opin Biol Ther"},{"key":"1056_CR17","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V82.8.2310.2310","volume":"82","author":"WR Drobyski","year":"1993","unstructured":"Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood. 1993;82:2310\u20138.","journal-title":"Blood"},{"key":"1056_CR18","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1200\/JCO.2007.11.6053","volume":"25","author":"C Schmid","year":"2007","unstructured":"Schmid C, Labopin M, Nagler A, Bornhauser M, Finke J, Fassas A, et al. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol. 2007;25:4938\u201345.","journal-title":"J Clin Oncol"},{"key":"1056_CR19","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2002-02-0506","volume":"100","author":"DI Marks","year":"2002","unstructured":"Marks DI, Lush R, Cavenagh J, Milligan DW, Schey S, Parker A, et al. The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood. 2002;100:3108\u201314.","journal-title":"Blood"},{"key":"1056_CR20","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I","volume":"38","author":"EM McKelvey","year":"1976","unstructured":"McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, et al. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer. 1976;38:1484\u201393.","journal-title":"Cancer"},{"key":"1056_CR21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00042560-199606010-00012","volume":"12","author":"H Taguchi","year":"1996","unstructured":"Taguchi H, Kinoshita KI, Takatsuki K, Tomonaga M, Araki K, Arima N, et al. An intensive chemotherapy of adult T-cell leukemia\/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:182\u20136.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"1056_CR22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbmt.2008.03.010","volume":"14","author":"R Tanosaki","year":"2008","unstructured":"Tanosaki R, Uike N, Utsunomiya A, Saburi Y, Masuda M, Tomonaga M, et al. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia\/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant. 2008;14:702\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1056_CR23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","volume":"116","author":"M Hishizawa","year":"2010","unstructured":"Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood. 2010;116:1369\u201376.","journal-title":"Blood"},{"key":"1056_CR24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/0008-5472.CAN-03-1452","volume":"64","author":"N Harashima","year":"2004","unstructured":"Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M, et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 2004;64:391\u20139.","journal-title":"Cancer Res"},{"key":"1056_CR25","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.1128\/JVI.79.15.10088-10092.2005","volume":"79","author":"N Harashima","year":"2005","unstructured":"Harashima N, Tanosaki R, Shimizu Y, Kurihara K, Masuda T, Okamura J, et al. Identification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation. J Virol. 2005;79:10088\u201392.","journal-title":"J Virol"},{"key":"1056_CR26","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1200\/JCO.1995.13.7.1800","volume":"13","author":"JC Byrd","year":"1995","unstructured":"Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13:1800\u201316.","journal-title":"J Clin Oncol"},{"key":"1056_CR27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.bmt.1704223","volume":"32","author":"KH Lee","year":"2003","unstructured":"Lee KH, Lee JH, Choi SJ, Kim S, Seol M, Lee YS, et al. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant. 2003;32:835\u201342.","journal-title":"Bone Marrow Transplant"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1056-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1056-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1056-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T13:01:41Z","timestamp":1593954101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1056-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1056-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,6]]}}}